New diabetes clinical trial: GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)

Published on: 2026-07-31T04:00:00Z
Conditions: Breast Cancer (Locally Advanced or Metastatic)
Interventions: Drug: GB268; Drug: Nab-Paclitaxel; Drug: Datopotamab Deruxtecan (Dato-DXd); Drug: Sacituzumab Tirumotecan
Sponsors: Eddingpharm (Zhuhai) Co., Ltd.
Not yet recruiting
https://ift.tt/Lgp6kGn